Top compounds associated with response to R3HDM4


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan FIMM pan-cancer AAC 0.34 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.082 0.03
mRNA PIK-93 GDSC1000 pan-cancer AAC -0.064 0.03
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC 0.075 0.03
mRNA Dasatinib CTRPv2 pan-cancer AAC 0.08 0.03
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.03
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.081 0.03
mRNA PF-4708671 GDSC1000 pan-cancer AAC 0.075 0.03
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.065 0.03
Download CSV